Castle’s innovative pipeline initiative to develop a genomic test aimed at guiding systemic therapy selection for patients with moderate-to-severe atopic dermatitis, psoriasis and related conditions ...
Earlier this year, I had the privilege of serving on the organizing committee for the DataTune conference in my hometown of Nashville, Tenn. Unlike many database-specific or platform-specific ...
Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn More Prophecy, a company providing a low-code platform for data engineering, ...
The first dimension is the most fundamental: statistical fidelity. It is not enough for synthetic data to look random. It must behave like real data. This means your distributions, cardinalities, and ...
Test automation and DevOps play a major role in today's quality assurance landscape. As we know, software development is evolving at a rapid pace. This requires finding robust ways to invest in ...
FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced new data showing the ability ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results